
CDC Signs Off on Pfizer’s COVID-19 Vaccine for Children Aged 5-11 Years
CDC Director Rochelle Walensky officially endorsed Pfizer's COVID-19 vaccine in children aged 5 to 11 years, following recommendation from ACIP.
Children aged 5 to 11 years can now receive the Pfizer-BioNTech mRNA COVID-19 vaccine, according to a November 2, 2021 press release from the US Centers for Disease Control and Prevention (CDC).
CDC Director Rochelle Walensky, MD, MPH, officially endorsed the
“We know millions of parents are eager to get their children vaccinated and with this decision, we now have recommended that about 28 million children receive a COVID-19 vaccine,” stated Walensky in the
The decision came days after the Food and Drug Administration
Clinical trials in children aged 5 to 11 years showed the vaccine was 90.7% effective in preventing COVID-19, and the immune responses in this age group were similar to those seen in persons aged 16 to 25 years. Safety data from the trials, which included approximately 3100 children who received Pfizer’s vaccine, found the most common side effects included injection site pain, headache, and fatigue. Side effects were mostly mild or moderate and generally subsided within 1 to 2 days.
Distribution of
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

































































































































































































































































































